CITIC M&A Fund, Legend Capital Lead $280M Investment In Pharmaron

Li Dongmei
December 14, 2015 — 11:20 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: China chinese chinese pharma CITIC contract research organization investment pharma pharmaceutical Private Equity technology

Related News:

China To Expand Investment Scope for Its National Social Security Fund

December 8, 2023 — 00:03

China Merchants Venture Co-leads Series A Round In IIoT Solution Provider

June 22, 2020 — 15:38

Redpoint, Sequoia Co-led $10M Series B Roun In Chinese Data Service Provider WakeData

May 11, 2020 — 16:20

Source Code Leads Series B Round In Chinese Service Robot Maker Keenlon

March 9, 2020 — 17:41

IDG Capital Leads $50M Round In Restaurant Supply Chain Startup Guoquan

February 24, 2020 — 23:32

Gaw Capital Partners Forms JV Partnership With Centrin Data To Develop IDC Projects In China

November 8, 2019 — 15:36

Sinochem To Launch A $713M Fund With Shandong Province For Environmental Protection

November 7, 2019 — 11:56

$14M Blockchain Fund To Launch In Response To Chinese Government’s Support

November 6, 2019 — 18:51

China’s State Fund Eyes $7B In Fundraising To Support Manufacturing Transformation

November 5, 2019 — 16:57

Franchising and Licensing Asia (FLAsia) 2024